Pauline Siew Mei Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pauline Siew Mei Lai has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Chirk Jenn Ng
SingHealth Polyclinics, Singapore, Singapore
8 shared publications Fadzilah Hanum Mohd Mydin
Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
6 shared publicationsPei Se Wong
International Medical University, Kuala Lumpur, Wilayah Persekutuan, Malaysia
6 shared publicationsSajaratulnisah Othman
Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
6 shared publications- Mun Kit Lim
Monash University - Malaysia Campus
5 shared publications - Sajaratulnisah Othman
Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
5 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0349144
Views, barriers, and facilitators of people living with human immunodeficiency virus and healthcare professionals regarding the use of a mobile health application to improve HIV self-care in Malaysia
Aim: The views, barriers, and facilitators of people living with HIV (PLWH) and healthcare professionals (HCPs), regarding the use of a mobile health application (m-HA) to improve HIV self-care were explored. Subject and Methods: Seventeen PLWH, nine doctors and two nurses who owned a smartphone and understood English or Malay were recruited from the infectious disease clinic of a tertiary hospital in Malaysia. Semi-structured in-depth interviews were conducted face-to-face using a topic guide, audio-recorded and transcribed verbatim. Data was analysed using reflexive thematic analysis. Two researchers independently coded transcripts and met to resolve discrepancies and develop themes. Data collection continued until thematic saturation was achieved. Results: Three themes emerged: (1) Perceived benefits and concerns regarding m-HA usage: participants perceived m-HA could improve knowledge, but expressed concerns regarding information overload. Participants viewed m-HA as a means to enhance access to hospital services like clinic visits, medication refills, communication with HCPs, and medical records documentation. However, concerns regarding misuse, data confidentiality and security remained. (2) Perceived motivators of m-HA: participants perceived that high utilitarian and hedonic motivators increase m-HA usage. (3) Perceived influences to use m-HA: participants believed PLWH would use m-HA if introduced by their peers or HCPs. Conclusion: These findings provided information for developing a patient-centred m-HA to improve HIV self-care in Malaysia.
- 22 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0349144
Open AccessViews, barriers, and facilitators of people living with human immunodeficiency virus and healthcare professionals regarding the use of a mobile health application to improve HIV self-care in Malaysia
Aim: The views, barriers, and facilitators of people living with HIV (PLWH) and healthcare professionals (HCPs), regarding the use of a mobile health application (m-HA) to improve HIV self-care were explored. Subject and Methods: Seventeen PLWH, nine doctors and two nurses who owned a smartphone and understood English or Malay were recruited from the infectious disease clinic of a tertiary hospital in Malaysia. Semi-structured in-depth interviews were conducted face-to-face using a topic guide, audio-recorded and transcribed verbatim. Data was analysed using reflexive thematic analysis. Two researchers independently coded transcripts and met to resolve discrepancies and develop themes. Data collection continued until thematic saturation was achieved. Results: Three themes emerged: (1) Perceived benefits and concerns regarding m-HA usage: participants perceived m-HA could improve knowledge, but expressed concerns regarding information overload. Participants viewed m-HA as a means to enhance access to hospital services like clinic visits, medication refills, communication with HCPs, and medical records documentation. However, concerns regarding misuse, data confidentiality and security remained. (2) Perceived motivators of m-HA: participants perceived that high utilitarian and hedonic motivators increase m-HA usage. (3) Perceived influences to use m-HA: participants believed PLWH would use m-HA if introduced by their peers or HCPs. Conclusion: These findings provided information for developing a patient-centred m-HA to improve HIV self-care in Malaysia.
- Open Access
- 4 May 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 314
Views, Barriers and Facilitators of Policymakers, Pharmacists and Community Health Representative in Managing Unused Medicine in a Socioeconomically Diverse District in Indonesia
Background Unused medicine poses a serious risk to community and environmental health. Several studies have been conducted on how patient behave. However little is known about how this issue is viewed through the lens of different stakeholders. Objective To explore the views, barriers and facilitators of policymakers, pharmacists and community-representative on community behavior in managing unused medicines in Garut Regency, Indonesia. Methods A qualitative study was conducted with policymakers, pharmacists and community -representatives. Data were analyzed inductively using thematic analysis framework. Emergent themes were further interpreted using the Socio-Ecological approach to situate behaviors and challenges within individual, community, organizational, and policy levels. Results Fourty one participants were recruited. Five themes were identified: (1) Storing and disposing medicines, (2) causes of unused medicines, (3) individual-level barriers including knowledge gaps and cultural beliefs, (4) structural barriers such as limited facilities, regulatory gaps, and institutional constraints, and (5) facilitators including rising awareness, supportive legal frameworks, and cross-sectoral initiatives. Mapping these findings onto the Socio-Ecological approach highlighted the interplay between patient practices, social norms, institutional resources, and policy environments. Conclusion Stakeholders recognize that unused medicine management is shaped by multi-level factors beyond individual awareness. Effective interventions will require a comprehensive approach that integrates patient education, community engagement, health system support, and regulatory frameworks.
- 4 May 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 314
Open AccessViews, Barriers and Facilitators of Policymakers, Pharmacists and Community Health Representative in Managing Unused Medicine in a Socioeconomically Diverse District in Indonesia
Background Unused medicine poses a serious risk to community and environmental health. Several studies have been conducted on how patient behave. However little is known about how this issue is viewed through the lens of different stakeholders. Objective To explore the views, barriers and facilitators of policymakers, pharmacists and community-representative on community behavior in managing unused medicines in Garut Regency, Indonesia. Methods A qualitative study was conducted with policymakers, pharmacists and community -representatives. Data were analyzed inductively using thematic analysis framework. Emergent themes were further interpreted using the Socio-Ecological approach to situate behaviors and challenges within individual, community, organizational, and policy levels. Results Fourty one participants were recruited. Five themes were identified: (1) Storing and disposing medicines, (2) causes of unused medicines, (3) individual-level barriers including knowledge gaps and cultural beliefs, (4) structural barriers such as limited facilities, regulatory gaps, and institutional constraints, and (5) facilitators including rising awareness, supportive legal frameworks, and cross-sectoral initiatives. Mapping these findings onto the Socio-Ecological approach highlighted the interplay between patient practices, social norms, institutional resources, and policy environments. Conclusion Stakeholders recognize that unused medicine management is shaped by multi-level factors beyond individual awareness. Effective interventions will require a comprehensive approach that integrates patient education, community engagement, health system support, and regulatory frameworks.
- Open Access
- 11 March 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (4) , 303
Deprescribing for patients nearing end of life: views, barriers and facilitators of palliative care patients, carers and nurses
Background The deprescribing process, which aims to reduce or stop unnecessary medications, remains an area with limited research, especially in patients nearing end of life. Therefore, we aimed to explore the views, barriers and facilitators of patients, their carers and community palliative care nurses about deprescribing for patients nearing end of life. Methods This qualitative study was conducted in Hospis Malaysia, Kuala Lumpur, between September 2021 and August 2022. We recruited patients on ≥ 5 medications, their carers who were ≥ 18 years, and community palliative care nurses from Hospis Malaysia. Nurses were recruited because they conducted home visits, could identify patients who may benefit from deprescribing, and could initiate deprescribing following consultation with physicians. Individual in-depth interviews were conducted using a topic guide. Thematic analysis was used to analyse the transcribed interviews. Results Five patients, 9 carers and 11 community palliative care nurses participated. Three themes emerged: (1) use of medications at end of life (2) social influences affecting deprescribing and (3) factors influencing deprescribing. Deprescribing was regarded as essential. Deprescribing was favoured when medication risks outweighed benefits, when medication was financially unsustainable, when swallowing difficulties arose, or when simplifying medication regimens was desired. Conversely, fears of medical relapse and perceived loss of hope acted as barriers. Nurses demonstrated a strong understanding of deprescribing and could implement deprescribing due to robust organisational support. Their confidence was bolstered by consistent guidance from hospice physicians and timely information from pharmacy teams. Conclusion Deprescribing was deemed essential for patients nearing end of life by patients, carers, and community palliative care nurses. Future research should broaden its scope to encompass diverse healthcare systems and settings, examining how cultural and professional factors influence end-of-life care, thus offering a more comprehensive understanding of deprescribing in various contexts.
- 11 March 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (4) , 303
Open AccessDeprescribing for patients nearing end of life: views, barriers and facilitators of palliative care patients, carers and nurses
Background The deprescribing process, which aims to reduce or stop unnecessary medications, remains an area with limited research, especially in patients nearing end of life. Therefore, we aimed to explore the views, barriers and facilitators of patients, their carers and community palliative care nurses about deprescribing for patients nearing end of life. Methods This qualitative study was conducted in Hospis Malaysia, Kuala Lumpur, between September 2021 and August 2022. We recruited patients on ≥ 5 medications, their carers who were ≥ 18 years, and community palliative care nurses from Hospis Malaysia. Nurses were recruited because they conducted home visits, could identify patients who may benefit from deprescribing, and could initiate deprescribing following consultation with physicians. Individual in-depth interviews were conducted using a topic guide. Thematic analysis was used to analyse the transcribed interviews. Results Five patients, 9 carers and 11 community palliative care nurses participated. Three themes emerged: (1) use of medications at end of life (2) social influences affecting deprescribing and (3) factors influencing deprescribing. Deprescribing was regarded as essential. Deprescribing was favoured when medication risks outweighed benefits, when medication was financially unsustainable, when swallowing difficulties arose, or when simplifying medication regimens was desired. Conversely, fears of medical relapse and perceived loss of hope acted as barriers. Nurses demonstrated a strong understanding of deprescribing and could implement deprescribing due to robust organisational support. Their confidence was bolstered by consistent guidance from hospice physicians and timely information from pharmacy teams. Conclusion Deprescribing was deemed essential for patients nearing end of life by patients, carers, and community palliative care nurses. Future research should broaden its scope to encompass diverse healthcare systems and settings, examining how cultural and professional factors influence end-of-life care, thus offering a more comprehensive understanding of deprescribing in various contexts.
- 1 March 2025
- Vol. 80 (2) , 118-126
Cross-cultural adaptation and validation of the Malay Adult cirrhosiS Knowledge Questionnaire (ASK-QM).
Cirrhosis is common in Malaysia, but no questionnaire in the local language (Malay) has been developed to assess patients' knowledge of this disease. This study aimed to adapt and validate the Malay Adult cirrhosiS Knowledge Questionnaire (ASK-QM). ASK-QM was translated from English to Malay according to international guidelines. It was validated among cirrhotic patient who understand Malay language from two major liver centers in Klang Valley, Malaysia (University of Malaya and Hospital Selayang) from January 2021 to March 2022, at week 0 and 2. Patients with hepatic encephalopathy were excluded. 121 out of 132 patients with cirrhosis agreed to participate (response rate=91.7%). The overall median score of the ASK-QM was 54.5 [38.6-68.2] and the difficulty factor was 0.5 (range: 0.1-0.8 for each domain). Confirmatory factor analysis showed a good model fit with results of Comparative fit index (CFI) ranging from 0.836 to 1.000, whilst, the Tucker-Lewis index (TLI) ranged from 0.690 to 1.004 across all four domains. The root mean square error of approximation (RMSEA) value was reported from 0.000 to 0.100. For standardized root mean squared residual (SRMR) was from 0.008 to 0.015. Patients with tertiary education scored higher compared to those without (63.6 [45.5-77.3] vs 52.3 [36.4-63.6], p0.005. The ASK-QM was found to be a valid and reliable questionnaire for evaluating knowledge of liver cirrhosis amongst Malay-speaking adults.
- 1 March 2025
- Vol. 80 (2) , 118-126
Cross-cultural adaptation and validation of the Malay Adult cirrhosiS Knowledge Questionnaire (ASK-QM).
Cirrhosis is common in Malaysia, but no questionnaire in the local language (Malay) has been developed to assess patients' knowledge of this disease. This study aimed to adapt and validate the Malay Adult cirrhosiS Knowledge Questionnaire (ASK-QM). ASK-QM was translated from English to Malay according to international guidelines. It was validated among cirrhotic patient who understand Malay language from two major liver centers in Klang Valley, Malaysia (University of Malaya and Hospital Selayang) from January 2021 to March 2022, at week 0 and 2. Patients with hepatic encephalopathy were excluded. 121 out of 132 patients with cirrhosis agreed to participate (response rate=91.7%). The overall median score of the ASK-QM was 54.5 [38.6-68.2] and the difficulty factor was 0.5 (range: 0.1-0.8 for each domain). Confirmatory factor analysis showed a good model fit with results of Comparative fit index (CFI) ranging from 0.836 to 1.000, whilst, the Tucker-Lewis index (TLI) ranged from 0.690 to 1.004 across all four domains. The root mean square error of approximation (RMSEA) value was reported from 0.000 to 0.100. For standardized root mean squared residual (SRMR) was from 0.008 to 0.015. Patients with tertiary education scored higher compared to those without (63.6 [45.5-77.3] vs 52.3 [36.4-63.6], p0.005. The ASK-QM was found to be a valid and reliable questionnaire for evaluating knowledge of liver cirrhosis amongst Malay-speaking adults.
- Open Access
- 6 January 2025
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 11 (1) , 2417788
Efficient and Effective Diabetes Care in the Era of Digitalization and Hypercompetitive Research Culture: A Focused Review in the Western Pacific Region with Malaysia as a Case Study
There are approximately 220 million (about 12% regional prevalence) adults living with diabetes mellitus (DM) with its related complications, and morbidity knowingly or unconsciously in the Western Pacific Region (WP). The estimated healthcare cost in the WP and Malaysia was 240 billion USD and 1.0 billion USD in 2021 and 2017, respectively, with unmeasurable suffering and loss of health quality and economic productivity. This urgently calls for nothing less than concerted and preventive efforts from all stakeholders to invest in transforming healthcare professionals and reforming the healthcare system that prioritizes primary medical care setting, empowering allied health professionals, improvising health organization for the healthcare providers, improving health facilities and non-medical support for the people with DM. This article alludes to challenges in optimal diabetes care and proposes evidence-based initiatives over a 5-year period in a detailed roadmap to bring about dynamic and efficient healthcare services that are effective in managing people with DM using Malaysia as a case study for reference of other countries with similar backgrounds and issues. This includes a scanning on the landscape of clinical research in DM, dimensions and spectrum of research misconducts, possible common biases along the whole research process, key preventive strategies, implementation and limitations toward high-quality research. Lastly, digital medicine and how artificial intelligence could contribute to diabetes care and open science practices in research are also discussed.
- 6 January 2025
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 11 (1) , 2417788
Open AccessEfficient and Effective Diabetes Care in the Era of Digitalization and Hypercompetitive Research Culture: A Focused Review in the Western Pacific Region with Malaysia as a Case Study
There are approximately 220 million (about 12% regional prevalence) adults living with diabetes mellitus (DM) with its related complications, and morbidity knowingly or unconsciously in the Western Pacific Region (WP). The estimated healthcare cost in the WP and Malaysia was 240 billion USD and 1.0 billion USD in 2021 and 2017, respectively, with unmeasurable suffering and loss of health quality and economic productivity. This urgently calls for nothing less than concerted and preventive efforts from all stakeholders to invest in transforming healthcare professionals and reforming the healthcare system that prioritizes primary medical care setting, empowering allied health professionals, improvising health organization for the healthcare providers, improving health facilities and non-medical support for the people with DM. This article alludes to challenges in optimal diabetes care and proposes evidence-based initiatives over a 5-year period in a detailed roadmap to bring about dynamic and efficient healthcare services that are effective in managing people with DM using Malaysia as a case study for reference of other countries with similar backgrounds and issues. This includes a scanning on the landscape of clinical research in DM, dimensions and spectrum of research misconducts, possible common biases along the whole research process, key preventive strategies, implementation and limitations toward high-quality research. Lastly, digital medicine and how artificial intelligence could contribute to diabetes care and open science practices in research are also discussed.
- 14 October 2023
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 24 (12) , 1831-1842
A Systematic Review of Non–Seriously Ill Community-Dwelling Asians’ Views on Advance Care Planning
- 14 October 2023
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 24 (12) , 1831-1842
A Systematic Review of Non–Seriously Ill Community-Dwelling Asians’ Views on Advance Care Planning
- 12 July 2023
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 89 (11) , 3340-3351
Integrating real‐world data in cost‐effectiveness analysis of universal HLA‐B*15:02 screening in Malaysia
Aims: Despite the availability of newer antiseizure medications, carbamazepine (CBZ) remains the gold standard. However, patients of Asian ancestry are susceptible to CBZ‐related severe cutaneous adverse reactions. Universal HLA‐B*15:02 screening is a promising intervention to address this. With the increasing recognition of integrating real‐world evidence in economic evaluations, the cost‐effectiveness of universal HLA‐B*15:02 screening was assessed using available real‐world data in Malaysia.Methods: A hybrid model of a decision tree and Markov model was developed to evaluate 3 strategies for treating newly diagnosed epilepsy among adults: (i) CBZ initiation without HLA‐B*15:02 screening (current practice); (ii) universal HLA‐B*15:02 screening prior to CBZ initiation; and (iii) alternative prescribing without HLA‐B*15:02 screening. The model was populated with real‐world inputs derived from the Malaysian population. From a societal perspective, base‐case analysis and sensitivity analyses estimated the costs and outcomes over a lifetime. Incremental cost‐effectiveness ratios were calculated.Results: In the base‐cases analysis, universal HLA‐B*15:02 screening yielded the lowest total costs and the highest total quality‐adjusted life years (QALYs) gained. Compared with current practice, universal screening was less costly by USD100 and more effective by QALYs increase of 0.1306, while alternative prescribing resulted in 0.1383 QALYs loss at additional costs of USD332. The highest seizure remission rate (56%) was estimated for universal HLA‐B*15:02 screening vs. current practice (54%) and alternative prescribing (48%).Conclusion: Our study suggests that universal HLA‐B*15:02 screening is a cost‐effective intervention in Malaysia. With the demonstrated value of real‐world evidence in economic evaluations, more relevant standardization efforts should be emphasized to better inform decision‐making.
- 12 July 2023
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 89 (11) , 3340-3351
Integrating real‐world data in cost‐effectiveness analysis of universal HLA‐B*15:02 screening in Malaysia
Aims: Despite the availability of newer antiseizure medications, carbamazepine (CBZ) remains the gold standard. However, patients of Asian ancestry are susceptible to CBZ‐related severe cutaneous adverse reactions. Universal HLA‐B*15:02 screening is a promising intervention to address this. With the increasing recognition of integrating real‐world evidence in economic evaluations, the cost‐effectiveness of universal HLA‐B*15:02 screening was assessed using available real‐world data in Malaysia.Methods: A hybrid model of a decision tree and Markov model was developed to evaluate 3 strategies for treating newly diagnosed epilepsy among adults: (i) CBZ initiation without HLA‐B*15:02 screening (current practice); (ii) universal HLA‐B*15:02 screening prior to CBZ initiation; and (iii) alternative prescribing without HLA‐B*15:02 screening. The model was populated with real‐world inputs derived from the Malaysian population. From a societal perspective, base‐case analysis and sensitivity analyses estimated the costs and outcomes over a lifetime. Incremental cost‐effectiveness ratios were calculated.Results: In the base‐cases analysis, universal HLA‐B*15:02 screening yielded the lowest total costs and the highest total quality‐adjusted life years (QALYs) gained. Compared with current practice, universal screening was less costly by USD100 and more effective by QALYs increase of 0.1306, while alternative prescribing resulted in 0.1383 QALYs loss at additional costs of USD332. The highest seizure remission rate (56%) was estimated for universal HLA‐B*15:02 screening vs. current practice (54%) and alternative prescribing (48%).Conclusion: Our study suggests that universal HLA‐B*15:02 screening is a cost‐effective intervention in Malaysia. With the demonstrated value of real‐world evidence in economic evaluations, more relevant standardization efforts should be emphasized to better inform decision‐making.
- Open Access
- 30 June 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-12
Weighing the necessities and concerns of deprescribing among older ambulatory patients and primary care trainees: a qualitative study
Background: Deprescribing can be a challenging and complex process, particularly for early career doctors such as primary care trainees. To date, there is limited data from patients’ and doctors’ perspectives regarding the deprescribing of medications in older persons, particularly from developing countries. This study aimed to explore the necessities and concerns of deprescribing in older persons among older ambulatory patients and primary care trainees. Methods: A qualitative study was conducted among patients and primary care trainees (known henceforth as doctors). Patients aged ≥ 60 years, having ≥ 1 chronic disease and prescribed ≥ 5 medications and could communicate in either English or Malay were recruited. Doctors and patients were purposively sampled based on their stage of training as family medicine specialists and ethnicity, respectively. All interviews were audio-recorded and transcribed verbatim. A thematic approach was used to analyse data. Results: Twenty-four in-depth interviews (IDIs) with patients and four focus group discussions (FGDs) with 23 doctors were conducted. Four themes emerged: understanding the concept of deprescribing, the necessity to perform deprescribing, concerns regarding deprescribing and factors influencing deprescribing. Patients were receptive to the idea of deprescribing when the term was explained to them, whilst doctors had a good understanding of deprescribing. Both patients and doctors would deprescribe when the necessity outweighed their concerns. Factors that influenced deprescribing were doctor-patient rapport, health literacy among patients, external influences from carers and social media, and system challenges. Conclusion: Deprescribing was deemed necessary by both patients and doctors when there was a reason to do so. However, both doctors and patients were afraid to deprescribe as they ‘didn’t want to rock the boat’. Early-career doctors were reluctant to deprescribe as they felt compelled to continue medications that were initiated by another specialist. Doctors requested more training on how to deprescribe medications.
- 30 June 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-12
Open AccessWeighing the necessities and concerns of deprescribing among older ambulatory patients and primary care trainees: a qualitative study
Background: Deprescribing can be a challenging and complex process, particularly for early career doctors such as primary care trainees. To date, there is limited data from patients’ and doctors’ perspectives regarding the deprescribing of medications in older persons, particularly from developing countries. This study aimed to explore the necessities and concerns of deprescribing in older persons among older ambulatory patients and primary care trainees. Methods: A qualitative study was conducted among patients and primary care trainees (known henceforth as doctors). Patients aged ≥ 60 years, having ≥ 1 chronic disease and prescribed ≥ 5 medications and could communicate in either English or Malay were recruited. Doctors and patients were purposively sampled based on their stage of training as family medicine specialists and ethnicity, respectively. All interviews were audio-recorded and transcribed verbatim. A thematic approach was used to analyse data. Results: Twenty-four in-depth interviews (IDIs) with patients and four focus group discussions (FGDs) with 23 doctors were conducted. Four themes emerged: understanding the concept of deprescribing, the necessity to perform deprescribing, concerns regarding deprescribing and factors influencing deprescribing. Patients were receptive to the idea of deprescribing when the term was explained to them, whilst doctors had a good understanding of deprescribing. Both patients and doctors would deprescribe when the necessity outweighed their concerns. Factors that influenced deprescribing were doctor-patient rapport, health literacy among patients, external influences from carers and social media, and system challenges. Conclusion: Deprescribing was deemed necessary by both patients and doctors when there was a reason to do so. However, both doctors and patients were afraid to deprescribe as they ‘didn’t want to rock the boat’. Early-career doctors were reluctant to deprescribe as they felt compelled to continue medications that were initiated by another specialist. Doctors requested more training on how to deprescribe medications.
- Open Access
- 20 June 2023
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 9 (2) , 60-69
A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022
- 20 June 2023
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 9 (2) , 60-69
Open AccessA summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022
- Open Access
- 31 December 2022
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 16 (12) , 1877-1886
Comparing the appropriateness of antimicrobial prescribing among medical patients in two tertiary hospitals in Malaysia
Introduction: Malaysia is an upper-middle-income country with national antimicrobial stewardship programs in place. However, hospitals in this country are faced with a high incidence of multidrug-resistant organisms and high usage of broad-spectrum antibiotics. Therefore, this study aimed to use a standardized audit tool to assess clinical appropriateness, guideline compliance, and prescribing patterns of antimicrobial use among medical patients in two tertiary hospitals in Malaysia to benchmark practice. Methodology: A prospective hospital-wide point prevalence survey was carried out by a multidisciplinary team in April 2019 at the University Malaya Medical Centre (UMMC) and the Hospital Canselor Tuanku Muhriz (HCTM), Kuala Lumpur, Malaysia. Data was collected from the patient’s electronic medical records and recorded using the Hospital National Antimicrobial Prescribing Survey toolkit developed by the National Centre for Antimicrobial Stewardship, Australia. Results: The appropriateness of prescriptions was 60.1% (UMMC) and 67% (HCTM), with no significant difference between the two hospitals. Compliance with guidelines was 60.0% (UMMC) and 61.5% (HCTM). Amoxicillin-clavulanic acid was the most commonly prescribed antimicrobial (UMMC = 16.9%; HCTM = 11.9%). Conclusions: The appropriateness of antimicrobial prescribing in medical wards, compliance with guidelines, and prescribing patterns were similar between the two hospitals in Malaysia. The survey identified several areas of prescribing that would need targeted AMS interventions.
- 31 December 2022
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 16 (12) , 1877-1886
Open AccessComparing the appropriateness of antimicrobial prescribing among medical patients in two tertiary hospitals in Malaysia
Introduction: Malaysia is an upper-middle-income country with national antimicrobial stewardship programs in place. However, hospitals in this country are faced with a high incidence of multidrug-resistant organisms and high usage of broad-spectrum antibiotics. Therefore, this study aimed to use a standardized audit tool to assess clinical appropriateness, guideline compliance, and prescribing patterns of antimicrobial use among medical patients in two tertiary hospitals in Malaysia to benchmark practice. Methodology: A prospective hospital-wide point prevalence survey was carried out by a multidisciplinary team in April 2019 at the University Malaya Medical Centre (UMMC) and the Hospital Canselor Tuanku Muhriz (HCTM), Kuala Lumpur, Malaysia. Data was collected from the patient’s electronic medical records and recorded using the Hospital National Antimicrobial Prescribing Survey toolkit developed by the National Centre for Antimicrobial Stewardship, Australia. Results: The appropriateness of prescriptions was 60.1% (UMMC) and 67% (HCTM), with no significant difference between the two hospitals. Compliance with guidelines was 60.0% (UMMC) and 61.5% (HCTM). Amoxicillin-clavulanic acid was the most commonly prescribed antimicrobial (UMMC = 16.9%; HCTM = 11.9%). Conclusions: The appropriateness of antimicrobial prescribing in medical wards, compliance with guidelines, and prescribing patterns were similar between the two hospitals in Malaysia. The survey identified several areas of prescribing that would need targeted AMS interventions.